Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.50%
#3 Velvet Velvet +35.70%
#4 Black Phoenix Black Phoenix +34.70%
#5 Akedo Akedo +14.19%
#6 DoubleZero DoubleZero +12.81%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.80%
#8 HOME HOME +11.06%
#9 Cross Cross +10.56%
#10 Pieverse Pieverse +9.40%
Coin of the day
Islamic Coin Islamic Coin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

RVPHW
Pozycja w akcjach #39800
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical... Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.
Cena akcji
$0.003
Ostatnia synchronizacja: 2025-12-12
Kapitalizacja rynkowa
$343.91K
Zmiana (1 dzień)
-16.67%
Zmiana (1 rok)
-90.23%
Kraj
US
Handel Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Kategoria

Healthcare
Historia ceny akcji dla Reviva Pharmaceuticals Holdings, Inc. (RVPHW)
Najwyższa cena zamknięcia: $0.01 dnia 2025-12-01

Najniższa cena zamknięcia: $0.33 dnia 2018-10-01
Historia cen akcji firmy Reviva Pharmaceuticals Holdings, Inc. od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 305.88%
2025 -96.70%
2024 -75.67%
2023 0.82%
2022 134.68%
2021 -39.09%
2020 167.36%
2019 -15.00%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $739.76 8.31%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $258.70 14.29%
BE